Table 2 RRT characteristics, complications, and outcomes by treatment group
CVVHF (n = 65) | EDHF (n = 80) | P-value | |
|---|---|---|---|
Blood flow, ml/minute | 213.03 ± 21.72 | 231.43 ± 18.26 | 0.005 |
Ultrafiltration per hour, ml | 149.09 ± 66.58 | 241.84 ± 92.64 | <0.001 |
Ultrafiltration per day, L | 3.20 ± 1.59 | 2.84 ± 1.09 | 0.110 |
Replacement flow, ml/kg/h | 29.42 ± 6.10 | 40.14 ± 8.19 | <0.001 |
Replacement flow, L/h | 19.32 ± 5.32 | 26.32 ± 6.64 | <0.001 |
Replacement flow, L/day | 4.64 ± 1.28 | 2.65 ± 0.75 | <0.001 |
The total time of renal support, days | 3.86 ± 1.55 | 3.41 ± 1.58 | 0.112 |
Anticoagulant, n (%) | |||
None | 10 (15.38) | 20 (25.00) | 0.355 |
Heparin/low molecular heparin | 35 (53.85) | 37 (46.25) | |
Others | 20 (27.69) | 23 (28.75) | |
Fluid balance during first 72 hours RRT, L | -0.46 ± 0.67 | 0.15 ± 0.37 | 0.019 |
MAP during first 72 hours RRT, mm Hg | 89.73 ± 20.01 | 83.79 ± 19.26 | 0.137 |
Complications, n (%) | |||
Bleeding | 14 (21.54) | 10 (12.50) | 0.145 |
Hypotension | 10 (15.39) | 21 (26.25) | 0.112 |
Hypokalemia | 33 (50.77) | 31 (38.75) | 0.147 |
Hypophosphatemia | 36 (55.38) | 23 (28.75) | 0.001 |
Primary outcome, n (%) | |||
Renal recovery-60 days | 33 (50.77) | 26 (32.50) | 0.026 |
Mortality-60 days | 29 (44.62) | 37 (46.25) | 0.844 |